메뉴 건너뛰기




Volumn 105, Issue 2, 2011, Pages 281-289

Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy

Author keywords

Antiangiogenic agents; Bevacizumab; CNS hemorrhage; Glioblastoma; Glioma; Stroke

Indexed keywords

BEVACIZUMAB; ENZASTAURIN; SUNITINIB; VANDETANIB;

EID: 82955249230     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0579-4     Document Type: Article
Times cited : (71)

References (26)
  • 1
    • 70449517400 scopus 로고    scopus 로고
    • Antiangiogenic therapies for high-grade glioma
    • 10.1038/nrneurol.2009.159 19826401 10.1038/nrneurol.2009.159 1:CAS:528:DC%2BD1MXhtlKhtLbE
    • AD Norden J Drappatz PY Wen 2009 Antiangiogenic therapies for high-grade glioma Nat Rev Neurol 5 610 620 10.1038/nrneurol.2009.159 19826401 10.1038/nrneurol.2009.159 1:CAS:528:DC%2BD1MXhtlKhtLbE
    • (2009) Nat Rev Neurol , vol.5 , pp. 610-620
    • Norden, A.D.1    Drappatz, J.2    Wen, P.Y.3
  • 3
    • 59949083263 scopus 로고    scopus 로고
    • Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
    • 10.1200/JCO.2008.16.3055 19114704 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D
    • TN Kreisl L Kim K Moore P Duic C Royce I Stroud N Garren M Mackey JA Butman K Camphausen J Park PS Albert HA Fine 2009 Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 740 745 10.1200/JCO.2008.16.3055 19114704 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D
    • (2009) J Clin Oncol , vol.27 , pp. 740-745
    • Kreisl, T.N.1    Kim, L.2    Moore, K.3    Duic, P.4    Royce, C.5    Stroud, I.6    Garren, N.7    MacKey, M.8    Butman, J.A.9    Camphausen, K.10    Park, J.11    Albert, P.S.12    Fine, H.A.13
  • 4
    • 67649092660 scopus 로고    scopus 로고
    • Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
    • 10.1215/15228517-2009-006 19332770 10.1215/15228517-2009-006 1:CAS:528:DC%2BD1MXhtlWht73P
    • EC Quant AD Norden J Drappatz A Muzikansky L Doherty D Lafrankie A Ciampa S Kesari PY Wen 2009 Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab Neuro Oncol 11 550 555 10.1215/15228517-2009-006 19332770 10.1215/15228517-2009-006 1:CAS:528:DC%2BD1MXhtlWht73P
    • (2009) Neuro Oncol , vol.11 , pp. 550-555
    • Quant, E.C.1    Norden, A.D.2    Drappatz, J.3    Muzikansky, A.4    Doherty, L.5    Lafrankie, D.6    Ciampa, A.7    Kesari, S.8    Wen, P.Y.9
  • 6
    • 70350724766 scopus 로고    scopus 로고
    • Thrombotic events in patients with cancer receiving antiangiogenesis agents
    • 10.1200/JCO.2009.22.3875 19704059 10.1200/JCO.2009.22.3875 1:CAS:528:DC%2BD1MXhtlKjtLvK
    • M Zangari LM Fink F Elice F Zhan DM Adcock GJ Tricot 2009 Thrombotic events in patients with cancer receiving antiangiogenesis agents J Clin Oncol 27 4865 4873 10.1200/JCO.2009.22.3875 19704059 10.1200/JCO.2009.22.3875 1:CAS:528:DC%2BD1MXhtlKjtLvK
    • (2009) J Clin Oncol , vol.27 , pp. 4865-4873
    • Zangari, M.1    Fink, L.M.2    Elice, F.3    Zhan, F.4    Adcock, D.M.5    Tricot, G.J.6
  • 7
    • 76649097338 scopus 로고    scopus 로고
    • Intracerebral and subarachnoid hemorrhage in patients with cancer
    • 10.1212/WNL.0b013e3181cef837 20142616 10.1212/WNL.0b013e3181cef837 1:CAS:528:DC%2BC3cXhs1yhu7c%3D
    • BB Navi JS Reichman D Berlin AS Reiner KS Panageas AZ Segal LM DeAngelis 2010 Intracerebral and subarachnoid hemorrhage in patients with cancer Neurology 74 494 501 10.1212/WNL.0b013e3181cef837 20142616 10.1212/WNL.0b013e3181cef837 1:CAS:528:DC%2BC3cXhs1yhu7c%3D
    • (2010) Neurology , vol.74 , pp. 494-501
    • Navi, B.B.1    Reichman, J.S.2    Berlin, D.3    Reiner, A.S.4    Panageas, K.S.5    Segal, A.Z.6    Deangelis, L.M.7
  • 8
    • 46049098410 scopus 로고    scopus 로고
    • Ischemic stroke in patients with primary brain tumors
    • 10.1212/01.wnl.0000314648.82924.6f 18541885 10.1212/01.wnl.0000314648. 82924.6f
    • TN Kreisl T Toothaker S Karimi LM DeAngelis 2008 Ischemic stroke in patients with primary brain tumors Neurology 70 2314 2320 10.1212/01.wnl. 0000314648.82924.6f 18541885 10.1212/01.wnl.0000314648.82924.6f
    • (2008) Neurology , vol.70 , pp. 2314-2320
    • Kreisl, T.N.1    Toothaker, T.2    Karimi, S.3    Deangelis, L.M.4
  • 9
    • 0026625163 scopus 로고
    • Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group
    • 1379970
    • HP Adams Jr RF Woolson J Biller W Clarke 1992 Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group Haemostasis 22 99 103 1379970
    • (1992) Haemostasis , vol.22 , pp. 99-103
    • Adams Jr., H.P.1    Woolson, R.F.2    Biller, J.3    Clarke, W.4
  • 11
    • 52949130889 scopus 로고    scopus 로고
    • What is the risk of intracranial bleeding during anti-VEGF therapy?
    • 10.1215/15228517-2008-010 18539884 10.1215/15228517-2008-010
    • CP Carden JM Larkin MA Rosenthal 2008 What is the risk of intracranial bleeding during anti-VEGF therapy? Neuro Oncol 10 624 630 10.1215/15228517-2008- 010 18539884 10.1215/15228517-2008-010
    • (2008) Neuro Oncol , vol.10 , pp. 624-630
    • Carden, C.P.1    Larkin, J.M.2    Rosenthal, M.A.3
  • 12
    • 78049382933 scopus 로고    scopus 로고
    • Increased risk of serious hemorrhage with bevacizumab in cancer patients: A meta-analysis
    • 10.1159/000314980 21051914 10.1159/000314980 1:CAS:528: DC%2BC3MXhtlaltA%3D%3D
    • S Hapani A Sher D Chu S Wu 2010 Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis Oncology 79 27 38 10.1159/000314980 21051914 10.1159/000314980 1:CAS:528:DC%2BC3MXhtlaltA%3D%3D
    • (2010) Oncology , vol.79 , pp. 27-38
    • Hapani, S.1    Sher, A.2    Chu, D.3    Wu, S.4
  • 16
    • 57349153494 scopus 로고    scopus 로고
    • A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: A North American Brain Tumor Consortium (NABTC01-05)
    • 10.1007/s11060-008-9693-3 18797818 10.1007/s11060-008-9693-3 1:CAS:528:DC%2BD1MXjvFeiuw%3D%3D
    • N Butowski SM Chang L Junck LM DeAngelis L Abrey K Fink T Cloughesy KR Lamborn AM Salazar MD Prados 2009 A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) J Neurooncol 91 175 182 10.1007/s11060-008-9693-3 18797818 10.1007/s11060-008-9693-3 1:CAS:528:DC%2BD1MXjvFeiuw%3D%3D
    • (2009) J Neurooncol , vol.91 , pp. 175-182
    • Butowski, N.1    Chang, S.M.2    Junck, L.3    Deangelis, L.M.4    Abrey, L.5    Fink, K.6    Cloughesy, T.7    Lamborn, K.R.8    Salazar, A.M.9    Prados, M.D.10
  • 19
    • 79959956310 scopus 로고    scopus 로고
    • A phase I/II trial of the histone deacetylase inhibitor, romidepsin, for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
    • doi: 10.1093/neuonc/nor017
    • Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA (2011) A phase I/II trial of the histone deacetylase inhibitor, romidepsin, for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol. doi: 10.1093/neuonc/nor017
    • (2011) Neuro Oncol.
    • Iwamoto, F.M.1    Lamborn, K.R.2    Kuhn, J.G.3    Wen, P.Y.4    Yung, W.K.5    Gilbert, M.R.6    Chang, S.M.7    Lieberman, F.S.8    Prados, M.D.9    Fine, H.A.10
  • 21
    • 78149492402 scopus 로고    scopus 로고
    • Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
    • 10.1093/neuonc/noq025 20200024 10.1093/neuonc/noq025 1:CAS:528: DC%2BC3cXpvFSlt70%3D
    • FM Iwamoto KR Lamborn HI Robins MP Mehta SM Chang NA Butowski LM Deangelis LE Abrey WT Zhang MD Prados HA Fine 2010 Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) Neuro Oncol 12 855 861 10.1093/neuonc/noq025 20200024 10.1093/neuonc/noq025 1:CAS:528:DC%2BC3cXpvFSlt70%3D
    • (2010) Neuro Oncol , vol.12 , pp. 855-861
    • Iwamoto, F.M.1    Lamborn, K.R.2    Robins, H.I.3    Mehta, M.P.4    Chang, S.M.5    Butowski, N.A.6    Deangelis, L.M.7    Abrey, L.E.8    Zhang, W.T.9    Prados, M.D.10    Fine, H.A.11
  • 23
    • 77954382544 scopus 로고    scopus 로고
    • Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients
    • 10.1007/s11060-009-0098-8 20035366 10.1007/s11060-009-0098-8 1:CAS:528:DC%2BC3cXotlCnt78%3D
    • J Rieger O Bahr K Muller K Franz J Steinbach E Hattingen 2010 Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients J Neurooncol 99 49 56 10.1007/s11060-009-0098-8 20035366 10.1007/s11060-009-0098-8 1:CAS:528:DC%2BC3cXotlCnt78%3D
    • (2010) J Neurooncol , vol.99 , pp. 49-56
    • Rieger, J.1    Bahr, O.2    Muller, K.3    Franz, K.4    Steinbach, J.5    Hattingen, E.6
  • 24
    • 77949911509 scopus 로고    scopus 로고
    • Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab
    • 10.1200/JCO.2009.25.0233 19933906 10.1200/JCO.2009.25.0233
    • ER Gerstner MP Frosch TT Batchelor 2010 Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab J Clin Oncol 28 e91 e93 10.1200/JCO.2009.25.0233 19933906 10.1200/JCO.2009.25.0233
    • (2010) J Clin Oncol , vol.28
    • Gerstner, E.R.1    Frosch, M.P.2    Batchelor, T.T.3
  • 25
    • 1542268250 scopus 로고    scopus 로고
    • Nonconvulsive Status Epilepticus in Patients with Cancer: Imaging Abnormalities
    • DOI 10.1001/archneur.61.3.362
    • A Hormigo B Liberato E Lis LM DeAngelis 2004 Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities Arch Neurol 61 362 365 10.1001/archneur.61.3.362 15023812 10.1001/archneur.61.3.362 (Pubitemid 38327353)
    • (2004) Archives of Neurology , vol.61 , Issue.3 , pp. 362-365
    • Hormigo, A.1    Liberato, B.2    Lis, E.3    DeAngelis, L.M.4
  • 26
    • 34250365240 scopus 로고    scopus 로고
    • Mechanisms of adverse effects of anti-VEGF therapy for cancer
    • DOI 10.1038/sj.bjc.6603813, PII 6603813
    • T Kamba DM McDonald 2007 Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 1788 1795 10.1038/sj.bjc.6603813 17519900 10.1038/sj.bjc.6603813 1:CAS:528:DC%2BD2sXmtlyqur4%3D (Pubitemid 46912024)
    • (2007) British Journal of Cancer , vol.96 , Issue.12 , pp. 1788-1795
    • Kamba, T.1    McDonald, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.